Skip to content

Psilocybin: all studies

Page 382 of 441: studies 3,811 to 3,820 of 4,406, newest first. Back to the psilocybin overview

Research

Experts Offer Tips on Talking With Patients About Psychedelics

Psychiatric News June 28, 2023 Terri D’arrigo

Back to table of contents Previous article Next article Annual MeetingFull AccessExperts Offer Tips on Talking With Patients About PsychedelicsTerri D’ArrigoTerri D’ArrigoSearch for more papers by this authorPublished Online:28 Jun 2023https://doi.org/10.1176/appi.pn.2023.07.7.51AbstractPsychedelics differ from one another in their mechanism of action and potential effects on the body and mind....

DOI: 10.1176/appi.pn.2023.07.7.51 (opens in new tab) MDMA Counterculture Psychoanalysis Psychotherapist +2

Psychedelic Therapy Requires Enhanced Consent Discussions

Psychiatric News June 28, 2023 Nick Zagorski 1 citation

Back to table of contents Previous article Next article Annual MeetingFull AccessPsychedelic Therapy Requires Enhanced Consent DiscussionsNick ZagorskiNick ZagorskiPublished Online:28 Jun 2023https://doi.org/10.1176/appi.pn.2023.07.7.46AbstractThe presenters at an Annual Meeting session cautioned that patients pursuing psychedelic-assisted psychotherapy will benefit from physicians offering...

DOI: 10.1176/appi.pn.2023.07.7.46 (opens in new tab) Informed consent Psychotherapist Medical education Alternative medicine

Psychedelics, Meaningfulness, and the "Proper Scope" of Medicine: Continuing the Conversation.

Cambridge Quarterly of Healthcare Ethics June 27, 2023 Katherine Cheung, Kyle Patch, Brian D. Earp et al. 27 citations

Psychedelics such as psilocybin reliably produce significantly altered states of consciousness with a variety of subjectively experienced effects. These include certain changes to perception, cognition, and affect,1 which we refer to here as the acute subjective effects of psychedelics. In recent years, psychedelics such as psilocybin have also shown considerable promise as therapeutic agents...

DOI: 10.1017/s0963180123000270 (opens in new tab) Full text (opens in new tab) Psychedelics Mental health treatment Consciousness research Therapeutic medicine

KLASIKINIŲ PSICHODELIKŲ VEIKIMO MECHANIZMAI, BIOLOGINĖS SAVYBĖS IR TERAPINĖ NAUDA PACIENTAMS, TURINTIEMS PSICHIKOS SUTRIKIMŲ

Health Sciences June 22, 2023 Rapolas Šalaševičius, Gabrielė Pakriaušytė

Klasikiniai psichodelikai – tai natūralios (psilocibi­nas) arba sintetinės (LSD) medžiagos, stimuliuojančios 5-HT2A receptorius ir sukeliančios pakitusias regos, klau­sos, kognityvines ar nuotaikos būsenas. Šios medžiagos vis dažniau patraukia mokslo tyrėjų bendruomenės dė­mesį dėl jų potencialios naudos pacientams, sergantiems įvairaus spektro psichikos sutrikimais. Atlikę literatūros apžvalgą...

Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms

European Neuropsychopharmacology June 21, 2023 Seline Mock, Nicole Friedli, Patrick Pasi et al. 46 citations

Eating disorders are serious illnesses showing high rates of mortality and comorbidity with other mental health problems. Psychedelic-assisted therapy has recently shown potential in the treatment of several common comorbidities of eating disorders, including mood disorders, post-traumatic stress disorder, and substance use disorders. The theorized therapeutic mechanisms of psychedelic-assisted...

DOI: 10.1016/j.euroneuro.2023.05.008 (opens in new tab) Anxiety Anorexia nervosa Bulimia nervosa Eating disorders +7

[Paranoid hallucinatory psychosis following intoxication with fly agaric].

Der Nervenarzt June 19, 2023 Michael Soyka 1 citation

HintergrundPilzen kommt bei Intoxikationen eine große Bedeutung zu, wobei psychiatrische Aspekte oft kaum Erwähnung finden [21,22].Die Häufigkeit des Konsums halluzinogener Pilze in Europa ist noch niedrig mit einer 12-Monats-Prävalenz von maximal 1 % [2, 5, 8-11].Für Deutschland wurde sie mit immerhin 0,5 % (Männer 0,7 %, Frauen 0,4 %) angegeben [20].Gmel et al. [6] fanden für die Schweiz aber...

DOI: 10.1007/s00115-023-01511-6 (opens in new tab) Full text (opens in new tab) Amanita Hallucinations Paranoid disorders Psychotic disorders

In vivo mapping of pharmacologically induced functional reorganization onto the human brain’s neurotransmitter landscape

Science Advances June 14, 2023 Leor Roseman, Christopher Timmermann, Daniel Golkowski et al. 65 citations

To understand how pharmacological interventions can exert their powerful effects on brain function, we need to understand how they engage the brain’s rich neurotransmitter landscape. Here, we bridge microscale molecular chemoarchitecture and pharmacologically induced macroscale functional reorganization, by relating the regional distribution of 19 neurotransmitter receptors and transporters...

DOI: 10.1126/sciadv.adf8332 (opens in new tab) Pharmacology Neurotransmitter receptor Human brain

Is Microdosing a Placebo?

June 4, 2023 Vince Polito, Paul Liknaitzky 2 citations preprint

Some recent research and commentary have suggested that most or all the effects reported by people who microdose psychedelics may be explained by expectations or placebo effects. Here we step through all the available evidence from dose-controlled studies that have investigated the effects of low doses of LSD and psilocybin. We suggest eight reasons why current claims that microdosing is...

DOI: 10.31234/osf.io/3ykst (opens in new tab) Full text (opens in new tab) Placebo Expectancy theory Microdose Dose dependence +2

Tattoos and Trauma: Are Tattoos Healing for Trauma?

June 1, 2023 Krystal Bell, Krystal Bell 1 citation

Prior research and literature reviews suggest that there is medicinal value in tattooing for the healing of trauma. However, tattooing is still a burgeoning topic in academic studies and still mostly taboo as a western societal practice, so there are gaps in qualitative and quantitative data that could further validate the healing benefits of tattoos for trauma. This literature review analyzed...